PL1670309T3 - Transgeniczne zwierzęta z poważnymi zaburzeniami związanymi z chorobą Alzheimera - Google Patents

Transgeniczne zwierzęta z poważnymi zaburzeniami związanymi z chorobą Alzheimera

Info

Publication number
PL1670309T3
PL1670309T3 PL04787459T PL04787459T PL1670309T3 PL 1670309 T3 PL1670309 T3 PL 1670309T3 PL 04787459 T PL04787459 T PL 04787459T PL 04787459 T PL04787459 T PL 04787459T PL 1670309 T3 PL1670309 T3 PL 1670309T3
Authority
PL
Poland
Prior art keywords
alzheimer
disease
transgenic animals
disorders related
serious disorders
Prior art date
Application number
PL04787459T
Other languages
English (en)
Inventor
Louzao Caty Casas
Patrick Benoit
Laurent Pradier
Gunter Tremp
Jean-Michel Itier
Véronique Blanchard-Bregeon
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PL1670309T3 publication Critical patent/PL1670309T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/107—Rabbit
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0312—Animal model for Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/02—Cells from transgenic animals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL04787459T 2003-10-02 2004-09-27 Transgeniczne zwierzęta z poważnymi zaburzeniami związanymi z chorobą Alzheimera PL1670309T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0311578A FR2860391B1 (fr) 2003-10-02 2003-10-02 Animaux transgeniques presentant les troubles majeurs lies a la maladie d'alzheimer
PCT/FR2004/002436 WO2005032244A1 (fr) 2003-10-02 2004-09-27 Animaux transgeniques presentant les troubles majeurs lies a la maladie d'alzheimer
EP04787459A EP1670309B1 (fr) 2003-10-02 2004-09-27 Animaux transgeniques presentant les troubles majeurs lies a la maladie d'alzheimer

Publications (1)

Publication Number Publication Date
PL1670309T3 true PL1670309T3 (pl) 2010-11-30

Family

ID=34307379

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04787459T PL1670309T3 (pl) 2003-10-02 2004-09-27 Transgeniczne zwierzęta z poważnymi zaburzeniami związanymi z chorobą Alzheimera

Country Status (22)

Country Link
EP (1) EP1670309B1 (pl)
JP (1) JP4806635B2 (pl)
KR (1) KR101164691B1 (pl)
CN (1) CN1889826A (pl)
AT (1) ATE471661T1 (pl)
AU (1) AU2004277357B2 (pl)
BR (1) BRPI0415032A (pl)
CA (1) CA2540622C (pl)
CY (1) CY1110788T1 (pl)
DE (1) DE602004027823D1 (pl)
DK (1) DK1670309T3 (pl)
ES (1) ES2347961T3 (pl)
FR (1) FR2860391B1 (pl)
IL (1) IL174726A (pl)
MX (2) MXPA06003685A (pl)
NO (1) NO334611B1 (pl)
PL (1) PL1670309T3 (pl)
PT (1) PT1670309E (pl)
RU (1) RU2373707C2 (pl)
SI (1) SI1670309T1 (pl)
WO (1) WO2005032244A1 (pl)
ZA (1) ZA200602670B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2963791B1 (fr) * 2010-08-11 2012-09-21 Assist Publ Hopitaux De Paris Methode de diagnostic des maladies neurodegeneratives
JPWO2014007367A1 (ja) * 2012-07-05 2016-06-02 国立大学法人 東京大学 同一試料中の２種の物質を検出又は測定する方法
JP6583011B2 (ja) * 2016-01-20 2019-10-02 コニカミノルタ株式会社 酸性水溶液を用いた免疫染色スライドの洗浄方法
CN109776665B (zh) * 2019-02-02 2021-02-05 首都医科大学宣武医院 阿尔茨海默病新突变、其稳转细胞模型及医药用途
CN121204155A (zh) * 2025-12-01 2025-12-26 北京实验动物研究中心有限公司 一种app基因人源化突变载体以及非人动物模型的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2798556B1 (fr) * 1999-09-17 2004-02-27 Aventis Pharma Sa Nouveau modele animal de la maladie d'alzheimer presentant a la fois des plaques amyloides et des dysfonctionnements mitochondriaux
JP2003509071A (ja) * 1999-09-17 2003-03-11 アバンテイス・フアルマ・エス・アー アミロイド斑およびミトコンドリア機能障害を示すアルツハイマー病の新規の動物モデル
AU7530000A (en) * 1999-09-27 2001-04-30 Aventis Pharma S.A. Transgenic animal expressing a multiple mutated form of presenilin
AU2001276995C1 (en) * 2000-07-20 2006-10-26 Cephalon, Inc. Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring

Also Published As

Publication number Publication date
CA2540622C (fr) 2014-01-14
JP2007507217A (ja) 2007-03-29
RU2373707C2 (ru) 2009-11-27
MXPA06003685A (es) 2006-06-20
WO2005032244A1 (fr) 2005-04-14
MXPA06003670A (es) 2006-06-20
KR20060090988A (ko) 2006-08-17
ZA200602670B (en) 2007-07-25
PT1670309E (pt) 2010-09-28
EP1670309A1 (fr) 2006-06-21
ATE471661T1 (de) 2010-07-15
SI1670309T1 (sl) 2010-11-30
ES2347961T3 (es) 2010-11-26
CY1110788T1 (el) 2015-06-10
CA2540622A1 (fr) 2005-04-14
EP1670309B1 (fr) 2010-06-23
BRPI0415032A (pt) 2006-12-12
IL174726A (en) 2013-05-30
AU2004277357A1 (en) 2005-04-14
FR2860391A1 (fr) 2005-04-08
NO20061954L (no) 2006-06-26
IL174726A0 (en) 2006-08-20
AU2004277357B2 (en) 2011-11-03
FR2860391B1 (fr) 2006-01-27
JP4806635B2 (ja) 2011-11-02
KR101164691B1 (ko) 2012-07-11
NO334611B1 (no) 2014-04-22
DK1670309T3 (da) 2010-10-25
CN1889826A (zh) 2007-01-03
RU2006114692A (ru) 2007-11-10
DE602004027823D1 (de) 2010-08-05

Similar Documents

Publication Publication Date Title
ATE550338T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
IL186504A0 (en) Methods and compositions for treatment of cns disorders
CY2015025I2 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
SI2527315T1 (sl) Spojine, sestavki in metode za zdravljenje amiloidnih bolezni in sinukleinopatij, kot so Alzheimerjeva bolezen, diabetes tipa 2 in Parkinsonova bolezen
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
NO20053211D0 (no) Forbindelser for behandling av metabolske forstyrrelser.
EP1643986A4 (en) PHENYL ACARBOXYLATE BETA SECRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER
ATE440866T1 (de) Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten
EP1940373B8 (en) 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
DE502004006619D1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
EP1809601A4 (en) COMPOUNDS FOR ALZHEIMER'S DISEASE
EP1758854A4 (en) PYRROLIDIN-3-YL COMPOUNDS SUITABLE AS BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE
GB0329874D0 (en) Compounds useful for the treatment of diseases
IL177787A0 (en) 1-aminovyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease
ITMI20031311A0 (it) Formulazioni per il trattamento di disturbi artrosici
CY1110788T1 (el) Διαγονιδιακα ζωα τα οποια παρουσιαζουν σημαντικες διαταραχες σχετικες με την νοσο alzheimer
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
MY136718A (en) Sulfonamide compounds for the treatment of neurodegenerative disorders
ATE464048T1 (de) Behandlung von alzheimer-krankheit und verwandten zuständen
ATE437855T1 (de) (4,5,6,7-tetrahydro-1h-indol-7- yl)essigsäurederivate zur behandlung von alzheimer-krankheit
ATE402150T1 (de) Pyrazolaminverbindungen zur behandlung neurodegenerativer erkrankungen
EA200701815A1 (ru) 6-гетероарил-1,2,3,4,4а,10в-гексагидрофенантридины в качестве pde-4 ингибиторов для лечения воспалительных заболеваний
ATE401321T1 (de) Beta-lactame zur behandlung von erkrankungen des zns
WO2006033000A3 (en) N-ethyl hydroxyethylamine useful in treating cns conditions